Stay updated with breaking news from Cnbc marcus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Is there freedom of speech when you work for a big company not. Well debate the profits go to pot quite literally. Cnbcs marcus limonus goes inside californias market he is going to give us a sneak peek power lunch starts right now welcome, everybody, to power lunch. Im Tyler Mathisen i am never disappointed when jeff done lunlop is on fasfas one more time, the dow is at record, 22,135 on the verge of an 11day win streak and potentially its tenth Straight Record close. The s p 500 joining the party. Record interday high there up three points or. 14 check out some movers. Fibrogen, up 50 and on pace for its best daily performance ever, overwhelmingly positive Clinical Data on its lung fibrosis drug flip side, dean20 meanwhile, chipotle, lowest level in four years at 336. 50. Trouble more for chipotle. Brian . Hey, tyler, ....
Offering, yielding the 8 range. Thats juicy, tempting. But we start with Sheila Dharmarajan and a very controversial new drug, oxycodone very prone to abuse. This is a more potent variant. Yes, it is super potent. Its also super controversial. I want to talk a little about the drug because its important here. It is a painkiller marketed by a small company. The active ingredient is hydrocodo hydrocodone, the same stuff you find in vicodin but unlike vicodin, this is pure hydrocodone in a higher dosage form. Thats actually the positives of the drug because it makes it very effective for chronic pain sufferers and also avoids some of the liver issues connected with longterm use of acetaminophen. This has been controversial from the getgo. The fda approved it against the advice of its own advisory panel. That only happens about 10 to 15 of the time. Since that approval, critics have been calling for the fda to reverse its decision ....
Down about 48 points, 15,470. The industrial average settles out, look at the volume number on the light side. 540 million shares traded. The nasdaq gave up 11. 75, 3,654. And the s p 500 tonight down 6. 50 at 1,690. By the way, all of the major averages finishing off the lows of the day. Even though were down in the double digits, we had buyers throughout the session today. It was nonetheless, though, a downer for the broad market. Bob pisani, put things in perspective for us today on the heels of what has been a record setter for this market. Reporter the big story is the constant commentary from the fed officials here. Lets take a look at that, because that will determine what happens in the next couple of months. The bottom line is the fed hawks and fed doves seem to be aligning, and the concept is tapering is imminent. If not in september, certainly by december. Unless the data completely falls apart. The head of the cleveland head came out today, not a voting member, but she said ....